Theravance Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Market Capitalization	451	560	756	814	1,137	1,470	1,418	1,509	1,656	620	481
Market Cap Growth	-	-25.95%	-7.19%	-28.37%	-22.63%	3.64%	-6.03%	-8.88%	167.01%	28.98%	-
Enterprise Value	399	506	480	1,310	1,519	1,698	1,366	1,383	1,377	447	225
PE Ratio	-10.14	-10.14	0.87	-4.08	-4.09	-6.21	-6.58	-5.29	-8.68	-3.40	-2.03
PS Ratio	7.88	9.75	14.72	14.72	15.82	20.02	23.49	98.07	34.04	14.72	41.14
PB Ratio	2.13	2.63	1.71	-2.40	-3.74	-6.56	-27.49	13.10	4.73	2.55	1.66
P/FCF Ratio	-20.01	-20.01	-4.07	-3.85	-4.42	-6.09	-11.81	-7.42	-16.38	-3.62	-2.70
P/OCF Ratio	-20.73	-20.73	-4.04	-3.92	-4.54	-6.17	-12.56	-7.51	-16.73	-3.67	-2.75
EV/Sales Ratio	6.94	8.81	9.34	23.68	21.15	23.14	22.63	89.91	28.30	10.61	19.28
EV/EBITDA Ratio	-12.40	-12.40	0.45	-7.18	-5.63	-8.49	-6.47	-5.33	-7.82	-2.51	-0.99
EV/EBIT Ratio	-10.78	-10.78	0.45	-6.86	-5.47	-8.09	-6.34	-5.26	-7.68	-2.47	-0.98
EV/FCF Ratio	-18.08	-18.08	-2.58	-6.20	-5.91	-7.04	-11.38	-6.80	-13.61	-2.61	-1.26
Debt / Equity Ratio	0.23	0.23	0.12	-1.98	-2.23	-2.28	-8.81	1.94	0.64	-	-
Debt / EBITDA Ratio	-1.21	-1.21	0.05	-3.67	-2.51	-2.55	-2.15	-0.86	-1.26	-	-
Debt / FCF Ratio	-1.76	-1.76	-0.28	-3.17	-2.63	-2.12	-3.78	-1.10	-2.20	-	-
Quick Ratio	4.87	4.87	12.02	3.22	2.94	2.97	5.30	5.74	10.39	4.25	6.24
Current Ratio	5.39	5.39	12.31	4.26	3.18	3.03	5.41	6.06	10.73	4.80	6.68
Asset Turnover	0.13	0.13	0.10	0.14	0.13	0.16	0.13	0.03	0.12	0.14	0.04
Interest Coverage	-19.97	-19.97	166.04	-22.35	-32.52	-6.59	-20.57	-30.79	-127.60	-	-
Return on Equity (ROE)	-19.90%	-19.90%	1577.70%	59.70%	120.20%	143.90%	-2631.60%	-136.80%	-63.10%	-72.00%	-95.20%
Return on Assets (ROA)	-12.40%	-12.40%	167.20%	-50.40%	-51.70%	-50.40%	-47.00%	-55.40%	-45.90%	-62.20%	-80.60%
Return on Capital (ROIC)	-21.37%	-21.37%	-15.45%	-77.89%	-79.90%	-87.87%	-59.28%	-76.75%	-31.50%	-74.84%	-80.24%
Earnings Yield	-12.19%	-9.86%	115.38%	-24.49%	-24.45%	-16.09%	-15.20%	-18.91%	-11.51%	-29.38%	-49.30%
FCF Yield	-6.18%	-5.00%	-24.57%	-25.94%	-22.60%	-16.42%	-8.47%	-13.48%	-6.11%	-27.65%	-37.07%
Buyback Yield / Dilution	24.85%	24.85%	-5.95%	-11.41%	-12.11%	-3.04%	-3.09%	-17.09%	-30.93%	-7.54%	-0.04%
Total Shareholder Return	24.85%	24.85%	-5.95%	-11.41%	-12.11%	-3.04%	-3.09%	-17.09%	-30.93%	-7.54%	-0.04%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).